DERM — Journey Medical Corp

—
Nasdaq · Health Care · Pharmaceuticals · CIK 1867066 ·
Last close
$3.90
Market Cap
$86.70M
52W High
$9.56
52W Low
$3.40
ADV30
218,520
Next earnings
2026-11-12
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topical formulation of minocycline for the treatment of inflammatory lesions of non-nodular moderate to severe acne vulgaris. It also provides Zilxi, a topical minocycline treatment for inflammatory lesions of rosacea; Emrosi for the treatment of inflammatory lesions of rosacea; Exelderm cream and solution for the treatment of fungal skin infections; and Targadox, an oral doxycycline drug for adjunctive therapy for severe acne, as well as Luxamend, a water-based emulsion formulated to provide a moist healing environment for superficial wounds; minor cuts or scrapes; dermal ulcers; donor sites; first- and second-degree burns, including sunburns; and radiation dermatitis. The company was formerly known as Coronado Dermatology, Inc. Journey Medical Corporation was incorporated in 2014 and is headquartered in Scottsdale, Arizona.

Quarterly Fundamentals

Revenues vs Net Income (last 4 Q)

Assets vs Liabilities (last 4 Q)

PeriodRevenuesGross profitOp incomeNet incomeAssetsCashLiabilities
Sep 2026 18,967,000 13,083,000 -530,000 -1,315,000 103,846,000 22,323,000 71,597,000
Jun 2026 18,510,000 12,367,000 456,000 -312,000 98,356,000 25,643,000 66,242,000
Mar 2026 15,961,000 9,743,000 -1,492,000 -2,230,000 91,534,000 27,219,000 60,703,000
Dec 2025 16,079,000 10,639,000 -443,000 -1,247,000 94,589,000 24,090,000 62,737,000

Cashflow TTM (yfinance, fills SEC gap)

Operating CF
$-7,492,000
Investing CF
—
Financing CF
$12,842,000
CapEx
—
Dividends Paid
—
Buybacks
—
EPS Diluted TTM
$-0.34
As of
2026-11-15

Balance + Analyst (yfinance extras)

Retained Earnings
$-101,000,000
Inventory
$8,156,000
Receivables
$36,246,000
ST Investments
—
EBIT TTM
$-2,421,000
Pretax Income TTM
$-6,089,000
Interest Exp TTM
$3,668,000
Analysts
3

Yahoo Snapshot (yfinance, live)

Total Revenue
$69,517,000
EBITDA
$2,120,000
Free Cash Flow
$-6,126,875
Enterprise Value
$125,536,696
Total Cash
$22,323,000
Total Debt
$25,621,000
Shares Out
22,230,645
Trailing EPS
$-0.18
Book Value
$1.14
ROE
-17.6%
ROA
-1.3%
Div Yield
0.00%

Annual Trend (SEC EDGAR, last 5y)

Revenues vs Net Income (last 5y)

FY endRevenuesOp incomeNet incomeAssetsLiabilitiesEquityOp cash flow
Dec 2025 61,858,000 -8,172,000 -11,431,000 94,589,000 62,737,000 31,852,000 -12,441,000
Dec 2024 56,134,000 -18,230,000 -14,672,000 80,241,000 60,172,000 20,069,000 -9,127,000
Dec 2023 79,181,000 1,070,000 -3,853,000 76,849,000 56,499,000 20,350,000 5,240,000
Dec 2022 73,669,000 -27,517,000 -29,628,000 105,160,000 88,178,000 16,982,000 -13,534,000
Dec 2021 — — — — — — —

TTM Snapshot

Revenues TTM
$68,181,000
NetIncome TTM
$-6,104,000
OpCashFlow TTM
—
Assets (Latest)
$98,356,000
Forward EPS
$-0.06

Max Pain — expiry 2027-02-19 (volume-derived — Yahoo OI feed degraded)

max pain strike: $5.00 · spot: $3.69 · call volume: 4 · put volume: 6

Peers — same industry

TickerNameMarket CapLastDaily %
RVRC Revium Rx. $86.84M $1.43 —
CPIX CUMBERLAND PHARMACEUTICALS INC $86.96M $5.80 —
HURA TuHURA Biosciences, Inc./NV $89.22M $1.40 —
NKTX Nkarta, Inc. $89.53M $1.25 —
ZOMDF Zomedica Corp. $83.30M $0.09 —

News headlines (Yahoo Finance, 1h cache)

Fortress Biotech (FBIO) Q3 2026 Earnings Call Transcript
2026-11-13 13:58 · Yahoo
Journey Medical Corporation Q3 2026 Earnings Call Summary
2026-11-13 13:30 · Yahoo
Journey Medical (DERM) Q3 2026 Earnings Call Transcript
2026-11-13 06:15 · Yahoo
Journey Medical Corp (DERM) Q3 2026 Earnings Call Highlights: Emrosi Momentum Drives Revenue ...
2026-11-13 05:03 · Yahoo
Fortress Biotech Q3 Earnings Call Highlights
2026-11-13 01:14 · Yahoo
What Journey Medical (DERM) Said on Its Q3 Earnings Call
2026-11-12 23:14 · Yahoo
Journey Medical (DERM) Reports Q3 Earnings: What Key Metrics Have to Say
2026-11-12 22:30 · Yahoo
Journey Medical Corporation (DERM) Reports Q3 Loss, Lags Revenue Estimates
2026-11-12 21:25 · Yahoo
Journey Medical Corporation Reports Third Quarter 2026 Financial Results and Recent Corporate Highlights
2026-11-12 21:01 · Yahoo
Journey Medical Corporation to Announce Third Quarter 2026 Financial Results on November 12, 2026
2026-11-05 13:30 · Yahoo

Recent Insider Activity

No insider activity indexed for this ticker.